Increasing glycaemic variability was associated with a higher risk of progression to end-stage kidney disease in patients with diabetes and chronic kidney disease (CKD) stage III or IV. The pattern of ...

Despite extensive research into patient-level differences in antidepressant treatment outcomes, the variability among clinicians themselves hasn’t been thoroughly evaluated. Understanding these ...

Please provide your email address to receive an email when new articles are posted on . In a retrospective pediatric cohort study, researchers observed 426 patients who underwent kidney-only ...

Skipping or Not Skipping? That's the Question! An Algorithm to Classify Novel MET Exon 14 Variants in Non–Small-Cell Lung Cancer Immune checkpoint inhibition enables immune cells to eliminate cancer ...

Using patient-reported outcomes (PROs) provides important insights from the patient's perspective and can be valuable to monitor and manage treatment-related adverse events during cancer treatment.

Beyond mean hemoglobin A1c, glycemic variability over time may be an additional risk factor for poor kidney outcomes. Greater glycemic variability portends worse kidney outcomes in patients with ...

The authors explore the limitations of the current system of revisit interval assignment and discuss the importance of standardization to optimize patient health care outcomes. Physicians often rely ...

An astonishing 4.8 billion people around the globe don't have proper access to surgical care. Although the rest of us can (and should) consider ourselves lucky, we must contend with another disturbing ...